Registration - Amendment

MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Period 3rd Quarter 2008 Filed Jul 21, 2008 Signed by Michael J. Eging, Vice President, Government Relations & Public Policy

Official filing
Firm
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Client
MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY
Income
—
Expenses
—

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING New —
THOMAS JOHN FUSSARO New —

Bills named: S. 2029 (110th), S. 1145 (110th), H.R. 1038 (110th), H.R. 5480 (110th)

Budget/Appropriations BUD

H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING New —
THOMAS JOHN FUSSARO New —

Bills named: S. 2029 (110th), H.R. 5480 (110th), H.R. 1038 (110th), S. 1145 (110th)

Pharmacy PHA

H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING New —
THOMAS JOHN FUSSARO New —

Bills named: H.R. 5480 (110th), H.R. 1038 (110th), S. 2029 (110th), S. 1145 (110th)

Copyright/Patent/Trademark CPT

H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING New —
THOMAS JOHN FUSSARO New —

Bills named: S. 2029 (110th), S. 1145 (110th), H.R. 5480 (110th), H.R. 1038 (110th)

Health Issues HCR

H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING New —
THOMAS JOHN FUSSARO New —

Bills named: H.R. 1038 (110th), H.R. 5480 (110th), S. 2029 (110th), S. 1145 (110th)

Medicare/Medicaid MMM

H. R. 5480, Medicare funding Warning Response Act of 2008 S. 2029, Physician Payments Sunshine Act of 2007 H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics S. 1145, Patent Reform Act of 2007, entire bill

LobbyistCovered position, as disclosed
MICHAEL J EGING New —
THOMAS JOHN FUSSARO New —

Bills named: S. 2029 (110th), H.R. 5480 (110th), S. 1145 (110th), H.R. 1038 (110th)

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
TAKEDA PHARMACEUTICALS COMPANY LIMITED Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.